These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9159163)

  • 21. The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine.
    Lin S; Lee SJ; Shim H; Chun J; Yun CC
    Am J Physiol Gastrointest Liver Physiol; 2010 Nov; 299(5):G1128-38. PubMed ID: 20724530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergent issues in the genetics of intestinal neoplasia.
    Dove WF; Gould KA; Luongo C; Moser AR; Shoemaker AR
    Cancer Surv; 1995; 25():335-55. PubMed ID: 8718526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of Apc+ in intestinal adenomas from Min mice.
    Luongo C; Moser AR; Gledhill S; Dove WF
    Cancer Res; 1994 Nov; 54(22):5947-52. PubMed ID: 7954427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult progression by Apc-deficient intestinal crypts as a target for chemoprevention.
    Fischer JM; Schepers AG; Clevers H; Shibata D; Liskay RM
    Carcinogenesis; 2014 Jan; 35(1):237-46. PubMed ID: 23996931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dnmt1N/+ reduces the net growth rate and multiplicity of intestinal adenomas in C57BL/6-multiple intestinal neoplasia (Min)/+ mice independently of p53 but demonstrates strong synergy with the modifier of Min 1(AKR) resistance allele.
    Cormier RT; Dove WF
    Cancer Res; 2000 Jul; 60(14):3965-70. PubMed ID: 10919675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of reciprocal congenic lines reveals the C3H/HeJ genome to be highly resistant to ApcMin intestinal tumorigenesis.
    Koratkar R; Silverman KA; Pequignot E; Hauck WW; Buchberg AM; Siracusa LD
    Genomics; 2004 Nov; 84(5):844-52. PubMed ID: 15475263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of guanylin is downregulated in mouse and human intestinal adenomas.
    Steinbrecher KA; Tuohy TM; Heppner Goss K; Scott MC; Witte DP; Groden J; Cohen MB
    Biochem Biophys Res Commun; 2000 Jun; 273(1):225-30. PubMed ID: 10873591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyclonality of familial murine adenomas: analyses of mouse chimeras with low tumor multiplicity suggest short-range interactions.
    Thliveris AT; Halberg RB; Clipson L; Dove WF; Sullivan R; Washington MK; Stanhope S; Newton MA
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6960-5. PubMed ID: 15870186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
    Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
    Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced tumor formation in mice heterozygous for Blm mutation.
    Goss KH; Risinger MA; Kordich JJ; Sanz MM; Straughen JE; Slovek LE; Capobianco AJ; German J; Boivin GP; Groden J
    Science; 2002 Sep; 297(5589):2051-3. PubMed ID: 12242442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
    Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
    Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic mapping of Mom5, a novel modifier of Apc(Min)-induced intestinal tumorigenesis.
    Oikarinen SI; Cleveland AG; Cork KM; Bynoté KK; Rafter JJ; Gustafsson JA; Mutanen M; Gould KA
    Carcinogenesis; 2009 Sep; 30(9):1591-6. PubMed ID: 19574546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.
    Roberts RB; Min L; Washington MK; Olsen SJ; Settle SH; Coffey RJ; Threadgill DW
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1521-6. PubMed ID: 11818567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam.
    Jacoby RF; Marshall DJ; Newton MA; Novakovic K; Tutsch K; Cole CE; Lubet RA; Kelloff GJ; Verma A; Moser AR; Dove WF
    Cancer Res; 1996 Feb; 56(4):710-4. PubMed ID: 8631000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergism between K-rasVal12 and mutant Apc accelerates murine large intestinal tumourigenesis.
    Luo F; Poulogiannis G; Ye H; Hamoudi R; Arends MJ
    Oncol Rep; 2011 Jul; 26(1):125-33. PubMed ID: 21573497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene.
    Oshima M; Oshima H; Kitagawa K; Kobayashi M; Itakura C; Taketo M
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4482-6. PubMed ID: 7753829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin receptor substrate-1 deficiency promotes apoptosis in the putative intestinal crypt stem cell region, limits Apcmin/+ tumors, and regulates Sox9.
    Ramocki NM; Wilkins HR; Magness ST; Simmons JG; Scull BP; Lee GH; McNaughton KK; Lund PK
    Endocrinology; 2008 Jan; 149(1):261-7. PubMed ID: 17916629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-catenin is essential in intestinal adenoma formation.
    Shibata H; Takano H; Ito M; Shioya H; Hirota M; Matsumoto H; Kakudo Y; Ishioka C; Akiyama T; Kanegae Y; Saito I; Noda T
    Proc Natl Acad Sci U S A; 2007 Nov; 104(46):18199-204. PubMed ID: 17989230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice.
    Hassan AB; Howell JA
    Cancer Res; 2000 Feb; 60(4):1070-6. PubMed ID: 10706126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ephrin-A1 promotes the malignant progression of intestinal tumors in Apc(min/+) mice.
    Shi L; Itoh F; Itoh S; Takahashi S; Yamamoto M; Kato M
    Oncogene; 2008 May; 27(23):3265-73. PubMed ID: 18246128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.